AI-generated summary
The authors ran a pilot trial in 21 adults with moderate plaque psoriasis, comparing a 307 nm excimer light device with twice-daily topical dithranol on paired lesions. They report that both treatments improved PSI scores by a mean of 3.0 points, that both were safe, and that the light device was more convenient and faster to administer. The authors describe the results as suggesting equal potency, but the pilot design is small.
- Participants
- 21
- Who or what was studied
- 21 adult patients with moderate plaque-type psoriasis
- Wavelengths
- 307 nm
- Limits stated in the abstract
- The abstract describes this as a small pilot trial, and the mean treatment period was only 9 days.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 307 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.